@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix hasPart: . @prefix ProteinComplex: . @prefix go: . @prefix hasAgent: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasPart: sub:_2, sub:_3; a ProteinComplex: . sub:_2 geneProductOf: hgnc:2365; a Protein: . sub:_3 geneProductOf: hgnc:903; a Protein: . sub:_4 hasAgent: sub:_5; a go:0042789 . sub:_5 geneProductOf: hgnc:2514; a Protein: . sub:_6 occursIn: species:9606; rdf:object sub:_4; rdf:predicate belv:decreases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "complex(p(HGNC:CRMP1),p(HGNC:AXIN1)) -| tscript(p(HGNC:CTNNB1))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_8; pav:version "1.4" . sub:_7 prov:value "background: (from text) Axin-1 is a negative regulator of the Wnt pathway that controls the levels of the transcriptional activator ?-catenin (Behrens et al., 1996). In the absence of Wnt signals, ?-catenin is degraded by an Axin-1-containing multiprotein complex , while activation of the pathway with, e.g., dishevelled (Dvl) inhibits ?-catenin degradation and induces Lef/Tcf-dependent transcription (Huelsken and Birchmeier, 2001). evidence: (from text) In the assay, moderate overexpression of Dvl in HEK293 cells caused a 4-fold increase in reporter gene activity. However, this increase was reduced to 1.5-fold in a dose-dependent manner, when full-length ANP32A or CRMP1 were coexpressed (Figure 6C). The activity of protein fragments in the Wnt signaling assay correlated with their ability to bind Axin-1. "; prov:wasQuotedFrom pubmed:16169070 . sub:_8 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:16169070; prov:wasDerivedFrom beldoc:, sub:_7 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:38.176+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }